-
-
-
-
-
-
-
InSite Vision Determines that an Unsolicited Offer from a Global Pharmaceutical Company to Acquire InSite for $0.35 per Share in Cash Constitutes a “Company Superior Proposal”
-
-
-
-
-
-
-
InSite Vision and QLT Amend Merger Agreement
-
-
-
-
-
-
-
InSite Vision Announces Completion of the New Drug Application Submission to the U.S. FDA for BromSite
-
-
-
-
1,157,969 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

